ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 2 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $222,000 | +54.2% | 10,813 | +49.5% | 0.00% | – |
Q2 2023 | $144,000 | -92.0% | 7,234 | -93.1% | 0.00% | – |
Q1 2023 | $1,795,000 | +784.2% | 104,765 | +909.0% | 0.00% | – |
Q4 2022 | $203,000 | +2155.6% | 10,383 | +1848.0% | 0.00% | – |
Q3 2022 | $9,000 | -96.5% | 533 | -97.2% | 0.00% | – |
Q2 2022 | $259,000 | +547.5% | 18,829 | +643.3% | 0.00% | – |
Q1 2022 | $40,000 | -79.5% | 2,533 | -71.7% | 0.00% | – |
Q4 2021 | $195,000 | +91.2% | 8,941 | +162.3% | 0.00% | – |
Q3 2021 | $102,000 | -15.0% | 3,409 | +25.3% | 0.00% | – |
Q2 2021 | $120,000 | -92.5% | 2,720 | -92.4% | 0.00% | – |
Q1 2021 | $1,592,000 | +19800.0% | 35,886 | +26286.8% | 0.00% | – |
Q4 2020 | $8,000 | +300.0% | 136 | -9.3% | 0.00% | – |
Q1 2020 | $2,000 | -92.3% | 150 | -86.7% | 0.00% | – |
Q4 2019 | $26,000 | +62.5% | 1,124 | +77.0% | 0.00% | – |
Q3 2018 | $16,000 | -52.9% | 635 | -63.5% | 0.00% | – |
Q2 2018 | $34,000 | -24.4% | 1,741 | -27.3% | 0.00% | – |
Q1 2018 | $45,000 | – | 2,394 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |